HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
Disclaimer: This content is for informational purposes only and is not intended as financial advice.
Upcoming Catalyst - Date: 23/05/2024
Investment Overview (Dated 27/04/2024):
Relative Volume: 3.90 Shares Float: 70.4 million
Significant Event - Date: 24/05/2024
Event: Hookipa to receive 10M from Roche following FDA clearance for a cancer trial. Key Technical Levels:
Resistance Levels: Watch for resistance at $1.00, $1.35, and $1.90. A break above these levels could indicate a potential upward movement. Consider taking partial profits at these thresholds to realize gains.
Trading Strategy:
Take Profit (TP): Set a profit target at approximately $2.90 to maximize returns.
Stop Loss (SL): Establish a stop loss strategy below $0.70 to minimize potential losses.
Chart Analysis:
Please refer to the accompanying chart for a detailed visual analysis of price actions and trend lines.
Trading Caution:
Trade with careful consideration of market conditions and personal risk tolerance. It is advised to conduct thorough research or consult with a financial advisor before making any investment decisions.
Все виды контента, которые вы можете увидеть на TradingView, не являются финансовыми, инвестиционными, торговыми или любыми другими рекомендациями. Мы не предоставляем советы по покупке и продаже активов. Подробнее — в Условиях использования TradingView.